Engineered Escherichia Coli for the in Situ Secretion of Therapeutic Nanobodies in the Gut
Dr. Cammie Lesser from Harvard University, USA will join Targeting Microbiota 2023 on October 17-19 to present her latest research "Engineered Escherichia Coli for the in Situ Secretion of Therapeutic Nanobodies in the Gut".
Join Targeting Microbiota 2023 to learn more about Dr. Lesser's talk.
You can share your related work by submitting your abstract.
Targeting Microbiota 2023 Congress
October 17-19, 2023 - Venice
Linkedin | Facebook | Website